CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYжурнал

Статьи, опубликованные в журнале

---

• 
  • 2025 An Integrative Mechanistic Model of Type 1 IFN‐Mediated Inflammation in Systemic Lupus Erythematosus
  • Volkova Alina, Sokolov Victor, Tettamanti Florencia, Verma Meghna, Ugolkov Yaroslav, Peskov Kirill, Tang Weifeng, Kimko Holly
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY DOI
• 
  • 2023 A mechanistic modeling platform of <scp>SGLT2</scp> inhibition: Implications for type 1 diabetes
  • Sokolov Victor, Yakovleva Tatiana, Stolbov Leonid, Penland Robert C., Boulton David, Parkinson Joanna, Tang Weifeng
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, том 12, № 6, с. 831-841 DOI
• • 2023 A tutorial for model‐based evaluation and translation of cardiovascular safety in preclinical trials
  • Kulesh Victoria, Vasyutin Igor, Volkova Alina, Peskov Kirill, Kimko Holly, Sokolov Victor, Alluri Ravindra
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, том 13, № 1, с. 5-22 DOI
• • 2022 A workflow for the joint modeling of longitudinal and event data in the development of therapeutics: Tools, statistical methods, and diagnostics
  • Zhudenkov Kirill, Gavrilov Sergey, Sofronova Alina, Stepanov Oleg, Kudryashova Nataliya, Helmlinger Gabriel, Peskov Kirill
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY DOI
• 
  • 2020 Differentiating the Sodium‐Glucose Cotransporter 1 Inhibition Capacity of Canagliflozin vs. Dapagliflozin and Empagliflozin Using Quantitative Systems Pharmacology Modeling
  • Sokolov Victor, Yakovleva Tatiana, Chu Lulu, Tang Weifeng, Greasley Peter J., Johansson Susanne, Peskov Kirill, Helmlinger Gabriel, Boulton David W., Penland Robert C.
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, том 9, № 4, с. 222-229 DOI
• 
  • 2020 Longitudinal tumor size and NLR are prognostic biomarkers for overall survival in patients with advanced NSCLC treated with durvalumab
  • Gavrilov Sergey, Zhudenkov Kirill, Helmlinger Gabriel, Dunyak James, Peskov Kirill, Aksenov Sergey
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY DOI
• 
  • 2019 Quantitative Systems Pharmacology: An Exemplar Model‐Building Workflow With Applications in Cardiovascular, Metabolic, and Oncology Drug Development
  • Helmlinger Gabriel, Sokolov Victor, Peskov Kirill, Hallow Karen M., Kosinsky Yuri, Voronova Veronika, Chu Lulu, Yakovleva Tatiana, Azarov Ivan, Kaschek Daniel, Dolgun Artem, Schmidt Henning, Boulton David W., Penland Robert C.
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, том 8, № 6, с. 380-395 DOI
• • 2017 A Translational Systems Pharmacology Model for A$\upbeta$ Kinetics in Mouse, Monkey, and Human
  • Karelina T., Demin O., Nicholas T., Lu Y., Duvvuri S., Barton H.A.
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY DOI
• • 2017 Studying the Progression of Amyloid Pathology and Its Therapy Using Translational Longitudinal Model of Accumulation and Distribution of Amyloid Beta
  • Karelina Tatiana, Demin Oleg, Duvvuri Sridhar, Nicholas Timothy
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY DOI
• 
  • 2016 A Mathematical Modeling Approach to Understanding the Effect of Anti-Interleukin Therapy on Eosinophils
  • Karelina T., Voronova V., Demin O., Colice G., Agoram B.M.
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, том 5, № 11, с. 608-616 DOI
• • 2014 A systems pharmacology perspective on the clinical development of Fatty Acid amide hydrolase inhibitors for pain
  • Benson N., Metelkin E., Demin O., Li GL, Nichols D., van_der_Graaf PH
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, том 3, с. e91 DOI
• 
  • 2013 Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors
  • Demin O., Karelina T., Svetlichniy D., Metelkin E., Speshilov G., Demin O.Jr, Fairman D., van der Graaf PH, Agoram BM
  • в журнале CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, том 2, с. e74 DOI